EN
HI
Summary
As of 10 Oct, 2026, Mankind Pharma stock price is ₹2368.5. During the trading session, the stock has moved between an intraday low of ₹2342.00 and an intraday high of ₹2389.80. Over the last 52 weeks, Mankind Pharma has traded between ₹1909.70 and ₹2642.00.
The stock has recorded a trading volume of 3,06,899 shares,. Its Average Traded Price (ATP) is ₹2369.78, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹2368.50.
Mankind Pharma has an upper circuit limit of ₹2605.30 and a lower circuit limit of ₹2131.70. The total value traded stands at ₹72.73 CR, and the delivery percentage for the day is 59.24%.
The stock is currently traded with a market lot size of 1. Mankind Pharma also offers a dividend yield of 0.04%.
Mankind Pharma Share Price Chart
Mankind Pharma Share Key Metrics
Volume
3.07 L
Market Cap
98304.73 CR
LTQ@LTP
2@2368.50
ATP
2369.78
Var Margin
14.65 %
Circuit Range
2131.7-2605.3
Delivery %
59.24 %
Value
72.73 CR
ASM/GSM
No
Market Lot
1
Mankind Pharma Fundamentals
P/E Ratio
47.9
P/B Ratio
5.82
Div. Yield
0.04
Sector P/E
41.33
Sector P/B
3.47
Sec. Div. Yield
0.53
Mankind Pharma Resistance and Support
Pivot 2412.83
Resistance
First Resistance
2478.06
Second Resistance
2576.13
Third Resistance
2641.36
Support
First Support
2314.76
Second Support
2249.53
Third Support
2151.46
Mankind Pharma Futures & Options
Mankind Pharma Option Chain
View Price, OI, Greeks & More...
27OCT26
2373.20
29.10 (1.24%)
23NOV26
2368.10
32.60 (1.40%)
29DEC26
2382.00
45.90 (1.96%)
MANKIND|27OCT26 CE 2360.00
68.75
9.8 (16.62%)
MANKIND|27OCT26 PE 2380.00
63.65
-26.5 (-29.4%)
Mankind Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 09 2026 | 2380 | 2368.5 | -0.48% | 2389.8 | 2342 |
| Thu Oct 08 2026 | 2501.1 | 2380 | -4.80% | 2510.89 | 2347.6 |
| Wed Oct 07 2026 | 2500.89 | 2500 | 0.00% | 2530 | 2480.1 |
Mankind Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-30 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-07-31 | Quarterly Results & Interim Dividend |
| 2025-05-21 | Audited Results |
| 2025-01-23 | Quarterly Results |
| 2024-11-05 | Quarterly Results |
Mankind Pharma News
Mankind Pharma Ltd - 543904 - Board Meeting Intimation for Adoption Of Unaudited Financial Results
Mankind Pharma's board will meet on October 26, 2026. The meeting will focus on approving the financial results for the quarter and half-year ended September 30, 2026.
Oct 08 2026 17:19:53
Mankind Pharma Ltd - 543904 - Intimation Regarding ESG Rating
Mankind Pharma has received an ESG rating of 68.21, categorized as 'Leader', from Niche99 ESG Ratings. This rating, for FY 2025-26, was independently prepared by Niche99 based on publicly available data.
Sep 15 2026 19:50:16
Mankind Pharma Management
| Name | Position |
|---|---|
| Hitesh Kumar Jain | Company Secretary & Compliance Officer |
| Ramesh Juneja | Chairman |
Mankind Pharma Similar Stocks
Lenskart Solutions Ltd.
677.65
23.70 (3.62%)
Zydus Lifesciences Ltd.
1117.50
5.50 (0.49%)
Apollo Hospitals Enterprise Ltd.
8027.50
361.50 (4.72%)
Laurus Labs Ltd.
2036.60
38.70 (1.94%)
Cipla Ltd.
1301.00
-5.80 (0.44%)
Dr. Reddy's Laboratories Ltd.
1197.00
17.00 (1.44%)
Aurobindo Pharma Ltd.
1693.00
48.00 (2.92%)
Manipal Health Enterprises Ltd.
701.30
17.25 (2.52%)
Lupin Ltd.
1956.50
19.60 (1.01%)
Max Healthcare Institute Ltd.
883.80
10.40 (1.19%)
Mankind Pharma FAQs
The Buying Price of Mankind Pharma share is 2368.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Mankind Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Mankind Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Mankind Pharma shares is 47.9. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Mankind Pharma shares is 5.82. Useful to assess the stock's value relative to its book value.
To assess Mankind Pharma’s valuation compare Sector P/E, P/B which are 41.33 & 3.47 with sector averages, along with growth rates and financial metrics.
The Market Cap of Mankind Pharma is 98304.73 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Mankind Pharma share price is 2642.00 & 1909.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Mankind Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in MANKIND
